HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Office of Cosmetics & Colors funding

This article was originally published in The Rose Sheet

Executive Summary

FDA cosmetics office budget set at $3.1 mil. for fiscal 2002, according to FDA budget office. Funding includes salary increases for employees and addition of one new full time equivalent. Office is allotted 31 FTEs compared to last year's 30, FDA says. President Bush signed Agriculture appropriations bill providing FDA with $1.35 bil. in funding Nov. 28 (1"The Rose Sheet" Dec. 3, In Brief)...

You may also be interested in...

Ag approps

President Bush approves agriculture appropriations bill Nov. 28; public law 107-76 provides FDA with $1.35 bil. in FY 2002, designates $1.5 mil. for Center for Food Safety and Applied Nutrition to revamp its dietary supplement adverse event monitoring system, which could lead to consolidation of five AER systems for cosmetics, food and color additives, foods and supplements (1"The Rose Sheet" April 16, p. 6)...

Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 

Stockwatch: Choppy Waters For Teva And Bausch

After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.






Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts